2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations
Ovarian cancer peritoneal carcinomatosis requires a multimodal-treatment approach. Current treatment considerations are analyzed in this update and include the management of recurrent malignant ascites and the understanding of its pathophysiology, the role of peritoneal washing cytology in detecting...
Main Authors: | Evgenia Halkia, George Chrelias, Charalambos Chrelias, Jesus Esquivel |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/5284814 |
Similar Items
-
Falsely Elevated CA 15-3 Levels in Ovarian Sarcoidosis with Peritoneal Involvement and Ascites
by: Sotirios Tsiodras, et al.
Published: (2018-01-01) -
Diagnosis and Management of Peritoneal Metastases from Ovarian Cancer
by: Evgenia Halkia, et al.
Published: (2012-01-01) -
Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
by: J. D. Spiliotis, et al.
Published: (2014-01-01) -
Tuberculous Peritonitis Associated with Ovarian Teratoma Presenting as Peritoneal Carcinomatosis
by: Chun-Yuan Su, et al.
Published: (2005-06-01) -
Intraperitoneal splenosis mimics peritoneal carcinomatosis of leiomyosarcoma and ovarian cancer
by: Yu-Chien Lin, et al.
Published: (2020-09-01)